Free Trial

ANEW Medical Q2 2024 Earnings Report

ANEW Medical EPS Results

Actual EPS
-$0.03
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

ANEW Medical Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

ANEW Medical Announcement Details

Quarter
Q2 2024
Time
N/A

Conference Call Resources

ANEW Medical Earnings Headlines

January 29th - the next big trading catalyst to watch
Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO the market… Unleashing more explosive moves than ever before.
ANEW MEDICAL, INC. Appoints New CFO
See More ANEW Medical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like ANEW Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ANEW Medical and other key companies, straight to your email.

About ANEW Medical

ANEW Medical (NASDAQ:WENA), a biopharmaceutical company, develops therapies for neurological and age-related disorders, and specialty diagnostics. Its products include cell and gene therapies to mitigate age-related pathologies, such as dementia symptoms, and Alzheimer and neuromuscular diseases; biologics/biosimilars in the treatment of cancer; and melanocortin receptors. The company has a strategic partnership with Japan's Okinawa Research Center for the research and development of Klotho gene therapy in enhancing longevity and reducing age-related diseases. Anew Medical, Inc. is based in Omaha, Nebraska.

View ANEW Medical Profile

More Earnings Resources from MarketBeat